Postdoctoral Research Award supports postdoctoral investigators studying Friedreich’s ataxia, funding basic science, drug development, and clinical research to advance treatments and a cure.
Funder: Friedreich's Ataxia Research Alliance
Due Dates: October 15, 2026 (Round 2 application) | February 15, 2027 (Round 1 LOI) | April 15, 2027 (Round 1 application) | August 15, 2027 (Round 2 LOI)
Funding Amounts: Up to $100,000 per year for 1 or 2 years
Summary: Supports postdoctoral investigators conducting Friedreich’s ataxia research, from basic science through drug development and clinical studies.
Key Information: The postdoctoral trainee must be PI, have 18 months to fewer than 6 years of postdoctoral training, and commit at least 75% effort.
The Friedreich’s Ataxia Research Alliance (FARA) offers this award to expand and retain young investigators in the Friedreich’s ataxia (FA) biomedical research field. It supports work spanning basic research, drug development, and clinical research, connecting studies of disease pathology with efforts to develop treatments and a cure.
Projects must align with at least one FARA research priority. These encompass neuroscience and affected systems, cardiac disease, the molecular basis of FA, drug discovery, translational research and drug development, and clinical research. The award also emphasizes career development: applicants describe their future involvement in FA research and how the proposed project, research environment, and mentoring will support their goals. Competitive candidates demonstrate qualities that strengthen FARA’s efforts to understand FA and advance therapeutic development.